Thirty-Day Outcomes After Bilateral Total Hip Arthroplasty in a Nationwide Cohort.
Bilateral
Infection
Outcomes
Total hip arthroplasty
Transfusion
Journal
Arthroplasty today
ISSN: 2352-3441
Titre abrégé: Arthroplast Today
Pays: United States
ID NLM: 101681808
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
15
11
2019
revised:
27
04
2020
accepted:
28
04
2020
entrez:
25
6
2020
pubmed:
25
6
2020
medline:
25
6
2020
Statut:
epublish
Résumé
Approximately 42% of patients with end-stage osteoarthritis have bilateral disease. Although bilateral total hip arthroplasty (THA) is physiologically demanding, certain patients may benefit from simultaneous rather than staged bilateral procedures. This study examines the intraoperative differences and 30-day outcomes in patients receiving bilateral THA compared with those who underwent unilateral THA. Patients undergoing THA were selected from the National Surgical Quality Improvement Program database from 2008 to 2015. Patients were selected according to those with primary and concurrent coding for Current Procedural Terminology 27130. Thirty-day complications were recorded, and multivariate analyses were performed to determine whether concurrent THA was a risk factor for poor outcomes. A total of 97,804 patients and 587 patients who underwent unilateral and bilateral THA, respectively, were identified. Patients who underwent bilateral procedures were younger (57.3 vs 64.6 years, Although bilateral THA recipients are younger with fewer preoperative comorbidities, bilateral THA is associated with an increased rate of transfusion in a nationwide setting. With this knowledge, specific interventions should be instituted to target these procedure-specific risks.
Sections du résumé
BACKGROUND
BACKGROUND
Approximately 42% of patients with end-stage osteoarthritis have bilateral disease. Although bilateral total hip arthroplasty (THA) is physiologically demanding, certain patients may benefit from simultaneous rather than staged bilateral procedures. This study examines the intraoperative differences and 30-day outcomes in patients receiving bilateral THA compared with those who underwent unilateral THA.
METHODS
METHODS
Patients undergoing THA were selected from the National Surgical Quality Improvement Program database from 2008 to 2015. Patients were selected according to those with primary and concurrent coding for Current Procedural Terminology 27130. Thirty-day complications were recorded, and multivariate analyses were performed to determine whether concurrent THA was a risk factor for poor outcomes.
RESULTS
RESULTS
A total of 97,804 patients and 587 patients who underwent unilateral and bilateral THA, respectively, were identified. Patients who underwent bilateral procedures were younger (57.3 vs 64.6 years,
CONCLUSIONS
CONCLUSIONS
Although bilateral THA recipients are younger with fewer preoperative comorbidities, bilateral THA is associated with an increased rate of transfusion in a nationwide setting. With this knowledge, specific interventions should be instituted to target these procedure-specific risks.
Identifiants
pubmed: 32577485
doi: 10.1016/j.artd.2020.04.020
pii: S2352-3441(20)30087-X
pmc: PMC7305265
doi:
Types de publication
Journal Article
Langues
eng
Pagination
405-409Informations de copyright
© 2020 Published by Elsevier Inc. on behalf of The American Association of Hip and Knee Surgeons.
Références
J Arthroplasty. 2016 Sep;31(9 Suppl):237-41
pubmed: 27067464
Clin Orthop Relat Res. 2009 Jan;467(1):28-31
pubmed: 18982399
Ann Surg. 2009 Sep;250(3):363-76
pubmed: 19644350
J Arthroplasty. 2014 Jan;29(1):142-8
pubmed: 23664280
J Arthroplasty. 2016 Feb;31(2):434-7
pubmed: 26411394
J Arthroplasty. 2015 Jul;30(7):1211-4
pubmed: 25737389
Curr Vasc Pharmacol. 2011 Jan;9(1):24-32
pubmed: 21044027
J Arthroplasty. 2017 Feb;32(2):689-695
pubmed: 27776901
Clin Orthop Relat Res. 2007 Oct;463:114-9
pubmed: 17960674
J Am Acad Orthop Surg. 2001 Sep-Oct;9(5):320-7
pubmed: 11575911
J Bone Joint Surg Br. 1981;63-B(3):354-6
pubmed: 7263745
Clin Orthop Relat Res. 2008 Jul;466(7):1710-5
pubmed: 18421542
J Bone Joint Surg Am. 2013 Oct 2;95(19):1777-83
pubmed: 24088970
Transfusion. 2005 Jan;45(1):103-10
pubmed: 15647025
Transfusion. 1991 Mar-Apr;31(3):212-7
pubmed: 2003322
Bull Hosp Joint Dis. 1971 Oct;32(2):198-214
pubmed: 5128234
J Bone Joint Surg Am. 2014 Sep 3;96(17):1476-84
pubmed: 25187587
J Knee Surg. 2011 Mar;24(1):25-31
pubmed: 21618935
Am J Orthop (Belle Mead NJ). 2016 Sep/Oct;45(6):E373-E378
pubmed: 27737297
J Arthroplasty. 2006 Feb;21(2):157-60
pubmed: 16520200
J Bone Joint Surg Am. 2014 Feb 19;96(4):279-84
pubmed: 24553883
J Arthroplasty. 2005 Jun;20(4):421-6
pubmed: 16124956
Acta Orthop Belg. 2016 Sep;82(3):497-508
pubmed: 29119890
J Arthroplasty. 2009 Dec;24(8):1174-7
pubmed: 19056233
Ann Rheum Dis. 1998 Dec;57(12):717-23
pubmed: 10070270
J Arthroplasty. 2018 Aug;33(8):2541-2545
pubmed: 29685712
J Bone Joint Surg Am. 2013 Mar 6;95(5):463-8
pubmed: 23467870
J Am Coll Surg. 2007 Jun;204(6):1089-102
pubmed: 17544068
J Am Coll Surg. 2010 Jan;210(1):6-16
pubmed: 20123325
J Arthroplasty. 2017 Oct;32(10):2974-2979.e1
pubmed: 28629904
J Arthroplasty. 2006 Sep;21(6 Suppl 2):26-31
pubmed: 16950058
J Arthroplasty. 2017 Nov;32(11):3328-3332
pubmed: 28602534
Bull Hosp Jt Dis (2013). 2015 Jun;73(2):78-82
pubmed: 26517159
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487
J Am Acad Orthop Surg. 2002 May-Jun;10(3):217-21
pubmed: 12041943
J Arthroplasty. 2014 Sep;29(9):1839-41
pubmed: 24890998
J Arthroplasty. 2007 Sep;22(6 Suppl 2):111-5
pubmed: 17823028